2023
DOI: 10.1101/2022.12.31.522370
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Massive solubility changes of neuronal proteins upon simulated traumatic brain injury reveal the role of shockwave in irreversible damage

Abstract: The immediate molecular consequences of traumatic brain injuries or TBI are poorly understood. Here, we simulated TBI using an innovative laboratory apparatus that employs a 5.1 kg dummy head holding neuronal cells and generating a less than or equal to 4,000 g-force acceleration upon impact. Dynamic impact led to both reduction in neuron viability and massive solubility changes in the proteome profiled using Proteome Integral Solubility Alteration (PISA) assay. The affected proteins mapped not only to the exp… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 69 publications
(81 reference statements)
0
0
0
Order By: Relevance
“…We have previously applied PISA for protein target identification and exploring mechanisms of small-molecule drugs 6,12 , biomarker discovery 16 , as well as for identification and prioritization of enzyme substrates 15,17 . In the current study, we tested the PISA performance as a higher-throughput technique for reliable drug target deconvolution on a larger set of drugs, choosing lung cancer as the application field (Figure 1).…”
Section: Introductionmentioning
confidence: 99%
“…We have previously applied PISA for protein target identification and exploring mechanisms of small-molecule drugs 6,12 , biomarker discovery 16 , as well as for identification and prioritization of enzyme substrates 15,17 . In the current study, we tested the PISA performance as a higher-throughput technique for reliable drug target deconvolution on a larger set of drugs, choosing lung cancer as the application field (Figure 1).…”
Section: Introductionmentioning
confidence: 99%